SCHEMBL17064848

SCHEMBL17064848

Brc1ccc(CCCC2CC2)cn1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.37
TRPV6 Q9H1D0 1/20 0.36
LNPEP Q9UIQ6 4/20 0.36
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PARP1 P09874 1/20 0.35
KCNH2 Q12809 1/20 0.34
CACNA1I Q9P0X4 1/20 0.34
NMT1 P30419 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19799224 0.79 CYP11B1 (0.39) CYP11B1TRPV6NPC1NFKB1MAPK1
SCHEMBL31508335 0.78 CYP11B1 (0.41) CYP11B1TRPV6PARP1KCNH2CACNA1I
SCHEMBL10484015 0.76 CYP11B1 (0.42) CYP11B1TRPV6NPC1NFKB1MAPK1
SCHEMBL4590967 0.76 CYP11B1 (0.42) CYP11B1TRPV6NPC1NFKB1MAPK1
SCHEMBL9085129 0.75 RAB9A (0.43) LNPEPNPC1NFKB1MAPK1RAB9A
SCHEMBL10483902 0.74 CYP11B1 (0.41) CYP11B1TRPV6NPC1NFKB1MAPK1
SCHEMBL17242029 0.74 CYP11B1 (0.41) CYP11B1TRPV6NPC1NFKB1MAPK1
SCHEMBL13430063 0.74 CYP11B1 (0.41) CYP11B1TRPV6NPC1NFKB1MAPK1
SCHEMBL20576042 0.74 CYP11B1 (0.41) CYP11B1NPC1NFKB1MAPK1RAB9A
SCHEMBL1134968 0.74 CYP11B1 (0.41) CYP11B1NPC1NFKB1MAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113772-A1 HUMAN PLASMA KALLIKREIN INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2017-01-11 EP disclosed
WO-2015134998-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2015-09-11 WO disclosed